A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator.

A. Zalmbumbide, S. Weening, S.J. Cramer, M.J. Rabelink, J. Verhaagen, R.C. Hoeben

Research output: Contribution to journal/periodical › Article › Scientific › peer-review

Access to Document

@article{f721fec917a8449da798154488a3ba35,

title = "A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator.",

author = "A. Zalmbumbide and S. Weening and S.J. Cramer and M.J. Rabelink and J. Verhaagen and R.C. Hoeben",

note = "Reporting year: 2010",

year = "2010",

doi = "10.1007/s10529-010-0218-8",

language = "English",

volume = "32",

pages = "749--754",

journal = "Biotechnology Letters",

issn = "0141-5492",

publisher = "Springer Netherlands",

}

TY - JOUR

T1 - A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator.

AU - Zalmbumbide, A.

AU - Weening, S.

AU - Cramer, S.J.

AU - Rabelink, M.J.

AU - Verhaagen, J.

AU - Hoeben, R.C.

N1 - Reporting year: 2010

PY - 2010

Y1 - 2010

U2 - 10.1007/s10529-010-0218-8

DO - 10.1007/s10529-010-0218-8

M3 - Article

VL - 32

SP - 749

EP - 754

JO - Biotechnology Letters

JF - Biotechnology Letters

SN - 0141-5492

ER -